Cargando…

MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1

BACKGROUND: MicroRNAs (miRs) have been implicated in the development and progression of osteosarcoma. Here, we aimed to illustrate the important role of miR-92a on the regulation of OS development which may help to establish a novel strategy for OS diagnosis and treatment. MATERIALS AND METHODS: Cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Quanxiang, Song, Yang, Duan, Xianliang, Chang, Yuan, Guo, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011149/ https://www.ncbi.nlm.nih.gov/pubmed/29984257 http://dx.doi.org/10.1155/2018/9870693

Ejemplares similares

The miR-17-92 cluster/QKI2/β-catenin axis promotes osteosarcoma progression
por: Yang, Hongbo, et al.
Publicado: (2018)

miR-222-3p promotes osteosarcoma cell migration and invasion through targeting TIMP3
por: Guo, Jianping, et al.
Publicado: (2018)

Upregulation of the miR-17-92 cluster and its two paraloga in osteosarcoma – reasons and consequences
por: Arabi, Leila, et al.
Publicado: (2014)

The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer
por: Zhao, Jian, et al.
Publicado: (2015)

miR-92a-3p regulates cisplatin-induced cancer cell death
por: Larrue, Romain, et al.
Publicado: (2023)

Differential Sensitivity of Target Genes to Translational Repression by miR-17~92
por: Jin, Hyun Yong, et al.
Publicado: (2017)

Phenotypic Characterization of miR-92a(−/−) Mice Reveals an Important Function of miR-92a in Skeletal Development
por: Penzkofer, Daniela, et al.
Publicado: (2014)

Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer
por: Zhang, Xinju, et al.
Publicado: (2018)

miR-30 inhibits the progression of osteosarcoma by targeting MTA1
por: Zhao, Aiqing, et al.
Publicado: (2022)

MiR-1208 Increases the Sensitivity to Cisplatin by Targeting TBCK in Renal Cancer Cells
por: Kim, Eun-Ae, et al.
Publicado: (2019)

Mangiferin Inhibits Human Lung Adenocarcinoma by Suppressing MiR-27b and MiR-92a
por: Chi, Xiao-Jv, et al.
Publicado: (2021)

MiR-92 suppresses proliferation and induces apoptosis by targeting EP4/Notch1 axis in gastric cancer
por: Shin, Vivian Yvonne, et al.
Publicado: (2018)

The expression profiling of serum miR-92a, miR-134 and miR-375 in acute ischemic stroke
por: Salman, Aya Tarek, et al.
Publicado: (2023)

A Chemotherapy-Driven Increase in Mcl-1 Mediates the Effect of miR-375 on Cisplatin Resistance in Osteosarcoma Cells
por: Liu, An-song, et al.
Publicado: (2019)

Knockdown of the oncogene lncRNA NEAT1 restores the availability of miR-34c and improves the sensitivity to cisplatin in osteosarcoma
por: Hu, Yuliang, et al.
Publicado: (2018)

MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer
por: Li, Jiarui, et al.
Publicado: (2012)

Upregulation of miR-138 Increases Sensitivity to Cisplatin in Hepatocellular Carcinoma by Regulating EZH2
por: Zeng, Taohui, et al.
Publicado: (2021)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
por: Schee, Kristina, et al.
Publicado: (2012)

Inhibition of TRIM32 Induced by miR-519d Increases the Sensitivity of Colorectal Cancer Cells to Cisplatin
por: Su, Xueliang, et al.
Publicado: (2020)

Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α
por: Keremu, Ajimu, et al.
Publicado: (2019)

Cisplatin inhibits the proliferation of Saos-2 osteosarcoma cells via the miR-376c/TGFA pathway
por: Wang, Yuan, et al.
Publicado: (2021)

Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a
por: Ohyashiki, Junko H, et al.
Publicado: (2010)

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
por: Zhou, Yong, et al.
Publicado: (2014)

miR-1271 enhances the sensitivity of colorectal cancer cells to cisplatin
por: Yao, Huixiang, et al.
Publicado: (2019)

Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia
por: Elhamamsy, Amr Rafat, et al.
Publicado: (2017)

miR-145, miR-92a and miR-375 Show Differential Expression in Serum from Patients with Diabetic Retinopathies
por: Solis-Vivanco, Adriana, et al.
Publicado: (2022)

Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells
por: Hu, Shien, et al.
Publicado: (2015)

NAIF1 suppresses osteosarcoma progression and is regulated by miR‐128
por: Kong, Daliang, et al.
Publicado: (2018)

Insights into Regulation of the miR-17-92 Cluster of miRNAs in Cancer
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2015)

The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma
por: Schwentner, Raphaela, et al.
Publicado: (2016)

Spatiotemporal plasticity of miRNAs functions: The miR-17-92 case
por: Bonaldi, Tiziana, et al.
Publicado: (2016)

miR-17 acts as a tumor suppressor by negatively regulating the miR-17-92 cluster
por: Sweat, Yan, et al.
Publicado: (2021)

MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells
por: Zhu, Ziqiang, et al.
Publicado: (2016)

miR-7 Increases Cisplatin Sensitivity of Gastric Cancer Cells Through Suppressing mTOR
por: Xu, Ning, et al.
Publicado: (2017)

MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression
por: Jingjing, Lin, et al.
Publicado: (2016)

Repression of LKB1 by miR-17∼92 Sensitizes MYC-Dependent Lymphoma to Biguanide Treatment
por: Izreig, Said, et al.
Publicado: (2020)

MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660
por: Shan, Hua-jian, et al.
Publicado: (2021)

Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma
por: Valera, Vladimir A., et al.
Publicado: (2011)

MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2
por: Liu, Yang, et al.
Publicado: (2017)

MiR-92a modulates proliferation, apoptosis, migration, and invasion of osteosarcoma cell lines by targeting Dickkopf-related protein 3
por: Yu, Haiyang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qi6h8ti7idp24baeod281e59i6